Clinical Trial

Estimating Insulin Sensitivity in Pregnancies With Type 1 Diabetes

Study acronym: EISP

Enrolling by Invitation

Summary

The investigators want to learn how the body's response to insulin changes during pregnancy in people with Type 1 Diabetes. In this study, the investigators will look at information from people who used a Dexcom continuous glucose monitor (CGM) and a Tandem insulin pump while they were pregnant. Participants will fill out an online survey and agree to share their device data. The investigators will use this information to see how insulin sensitivity changes from three months before pregnancy to six months after the baby is born.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2026-01-09; most recent amendment 2026-02-26.

Trial Details

NCT Number	NCT07351318
Lead Sponsor	University of Virginia Collaborators: Northwestern Memorial Hospital
Conditions	Pregnancy, Type 1 Diabetes (T1D)
Enrollment	100 participants
Start Date	2026-02-01
Primary Completion	2027-01 (estimated)
Study Completion	2027-03 (estimated)
Updated on ClinicalTrials.gov	2026-03-02